The purpose of this study was to determine the gadolinium (Gd) retention in human bone tissue after administration of Gd contrast agent such as macrocyclic (Gd-DOTA) or linear (Gd-DTPA-BMA) chelate at a standard single clinical dose and to evaluate its correlation with renal function.
This abstract and the presentation materials are available to members only; a login is required.